Converting HR+ Breast Cancer Into an Individualized Vaccine
Clinical trial NCT03804944 · RECRUITING
Trial details
- NCT number
- NCT03804944
- Sponsor
- Weill Medical College of Cornell University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-17
- Primary completion
- 2026-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.